Sanofi ADR Shares Outstanding vs. Current Valuation
| SNY Stock | USD 47.22 0.07 0.15% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.79 | 0.6152 |
|
| |||||
| Net Profit Margin | 0.18 | 0.1254 |
|
| |||||
| Operating Profit Margin | 0.23 | 0.2132 |
|
| |||||
| Pretax Profit Margin | 0.21 | 0.1661 |
|
| |||||
| Return On Assets | 0.0802 | 0.0427 |
|
| |||||
| Return On Equity | 0.13 | 0.0729 |
|
|
For Sanofi ADR profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sanofi ADR to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sanofi ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sanofi ADR's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sanofi ADR over time as well as its relative position and ranking within its peers.
Sanofi |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 1.93 | Revenue Per Share 18.492 | Quarterly Revenue Growth 0.023 | Return On Assets 0.0454 |
The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sanofi ADR Current Valuation vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sanofi ADR's current stock value. Our valuation model uses many indicators to compare Sanofi ADR value to that of its competitors to determine the firm's financial worth. Sanofi ADR is currently regarded as top stock in shares outstanding category among its peers. It also is currently regarded number one company in current valuation category among its peers reporting about 27.57 of Current Valuation per Shares Outstanding. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sanofi ADR's earnings, one of the primary drivers of an investment's value.Sanofi ADR's Earnings Breakdown by Geography
Sanofi Current Valuation vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Sanofi ADR |
| = | 2.5 B |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Sanofi ADR |
| = | 68.98 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Sanofi Current Valuation vs Competition
Sanofi ADR is currently regarded number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 1.56 Trillion. Sanofi ADR holds roughly 68.98 Billion in current valuation claiming about 4% of equities under Health Care industry.
Sanofi ADR Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sanofi ADR, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sanofi ADR will eventually generate negative long term returns. The profitability progress is the general direction of Sanofi ADR's change in net profit over the period of time. It can combine multiple indicators of Sanofi ADR, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 4.9 B | 4.6 B | |
| Operating Income | 9.2 B | 6.1 B | |
| Income Before Tax | 7.2 B | 5.5 B | |
| Total Other Income Expense Net | -2 B | -1.9 B | |
| Net Income | 5.4 B | 4.9 B | |
| Income Tax Expense | 1.6 B | 1.1 B | |
| Net Income Applicable To Common Shares | 9.6 B | 5.9 B | |
| Net Income From Continuing Ops | 5.4 B | 6.3 B | |
| Interest Income | 546 M | 573.3 M | |
| Net Interest Income | -639 M | -671 M | |
| Change To Netincome | -540 M | -567 M | |
| Net Income Per Share | 4.31 | 4.53 | |
| Income Quality | 1.90 | 1.30 | |
| Net Income Per E B T | 0.75 | 0.69 |
Sanofi Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sanofi ADR. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sanofi ADR position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sanofi ADR's important profitability drivers and their relationship over time.
Use Sanofi ADR in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sanofi ADR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanofi ADR will appreciate offsetting losses from the drop in the long position's value.Sanofi ADR Pair Trading
Sanofi ADR Pair Trading Analysis
The ability to find closely correlated positions to Sanofi ADR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sanofi ADR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sanofi ADR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sanofi ADR to buy it.
The correlation of Sanofi ADR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sanofi ADR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sanofi ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sanofi ADR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sanofi ADR position
In addition to having Sanofi ADR in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sport Products Thematic Idea Now
Sport Products
Companies manufacturing sporting goods and accessories. The Sport Products theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Sanofi Stock Analysis
When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.